Journal article icon

Journal article

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound

Abstract:
Although certain individuals with HIV infection can stop antiretroviral therapy (ART) without viral load rebound, the mechanisms under-pinning 'post-treatment control' remain unclear. Using RNA-Seq we explored CD4 T cell gene expression to identify evidence of a mechanism that might underpin virological rebound and lead to discovery of associated biomarkers. Fourteen female participants who received 12 months of ART starting from primary HIV infection were sampled at the time of stopping therapy. Two analysis methods (Differential Gene Expression with Gene Set Enrichment Analysis, and Weighted Gene Co-expression Network Analysis) were employed to interrogate CD4+ T cell gene expression data and study pathways enriched in post-treatment controllers versus early rebounders. Using independent analysis tools, expression of genes associated with type I interferon responses were associated with a delayed time to viral rebound following treatment interruption (TI). Expression of four genes identified by Cox-Lasso (ISG15, XAF1, TRIM25 and USP18) was converted to a Risk Score, which associated with rebound (p < 0.01). These data link transcriptomic signatures associated with innate immunity with control following stopping ART. The results from this small sample need to be confirmed in larger trials, but could help define strategies for new therapies and identify new biomarkers for remission
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41598-021-04212-9

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3645-662X
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1741-9353
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7774-7215
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-5256-4527
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-1095-5148


More from this funder
Funder identifier:
https://ror.org/01mzyze39


Publisher:
Nature Research
Journal:
Scientific Reports More from this journal
Volume:
12
Issue:
1
Pages:
462-462
Publication date:
2022-01-10
DOI:
EISSN:
2045-2322
ISSN:
2045-2322


Language:
English
Keywords:
Pubs id:
1231631
Local pid:
pubs:1231631
Source identifiers:
W4220955141
Deposit date:
2025-11-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP